EP1915131 - PROCESS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.01.2015 Database last updated on 19.10.2024 | Most recent event Tooltip | 09.01.2015 | Application deemed to be withdrawn | published on 11.02.2015 [2015/07] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2008/18] | Inventor(s) | 01 /
LINDFORS, Lennart AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | 02 /
SKANTZE, Urban AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | [2008/18] | Application number, filing date | 06769601.3 | 09.08.2006 | [2008/18] | WO2006SE00933 | Priority number, date | SE20050001807 | 12.08.2005 Original published format: SE 0501807 | [2008/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007021228 | Date: | 22.02.2007 | Language: | EN | [2007/08] | Type: | A1 Application with search report | No.: | EP1915131 | Date: | 30.04.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.02.2007 takes the place of the publication of the European patent application. | [2008/18] | Search report(s) | International search report - published on: | SE | 22.02.2007 | (Supplementary) European search report - dispatched on: | EP | 22.06.2012 | Classification | IPC: | A61K9/10, A61K31/16, A61K31/216, A61K31/4422 | [2012/30] | CPC: |
A61K9/10 (EP,KR,US);
A61K31/16 (EP,US);
A61K31/216 (EP,US);
A61K31/4422 (EP,US);
A61K9/107 (KR)
|
Former IPC [2008/18] | A61K9/10 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/18] | Extension states | HR | 12.03.2008 | Title | German: | VERFAHREN | [2008/18] | English: | PROCESS | [2008/18] | French: | PROCESSUS | [2008/18] | Entry into regional phase | 12.03.2008 | National basic fee paid | 12.03.2008 | Search fee paid | 12.03.2008 | Designation fee(s) paid | 12.03.2008 | Examination fee paid | Examination procedure | 12.03.2008 | Examination requested [2008/18] | 10.01.2013 | Amendment by applicant (claims and/or description) | 19.02.2014 | Despatch of a communication from the examining division (Time limit: M06) | 02.09.2014 | Application deemed to be withdrawn, date of legal effect [2015/07] | 30.09.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/07] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.02.2014 | Fees paid | Renewal fee | 28.03.2008 | Renewal fee patent year 03 | 31.08.2009 | Renewal fee patent year 04 | 31.08.2010 | Renewal fee patent year 05 | 31.08.2011 | Renewal fee patent year 06 | 31.08.2012 | Renewal fee patent year 07 | 02.09.2013 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.08.2014 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO03013472 (ASTRAZENECA AB [SE], et al) [X] 29-31 * page 22; example 1a * [I] 1-28; | [A]WO2004069226 (ASTRAZENECA AB [SE], et al) [A] 1-31* the whole document * | International search | [A]US5700471 (END LUTZ [DE], et al); | [A]US6074986 (MULQUEEN PATRICK JOSEPH [GB], et al); | [A]US6267989 (LIVERSIDGE ELAINE [US], et al); | [X]WO03013472 (ASTRAZENECA AB [SE], et al); | [A]WO03059319 (DOW GLOBAL TECHNOLOGIES INC [US]); | [A] - WELIN-BERGER K. ET AL., "Inhibition of Ostwald ripening in local anesthetic emulsions by using hydrophobic excipients in the disperse phase", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (2000), vol. 20, pages 249 - 260, XP002225985 DOI: http://dx.doi.org/10.1016/S0378-5173(00)00395-1 | Examination | EP0304227 |